Status:

ACTIVE_NOT_RECRUITING

Feasibility of Patient Selection and Treatment of Head-neck Cancer With Proton Therapy in Denmark

Lead Sponsor:

Danish Head and Neck Cancer Group

Conditions:

Head-and-neck Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

A study to investigate feasibility of local selection of patients with squamous cell carcinoma of the pharynx or larynx using anticipated benefit of proton radiotherapy in reducing the risk of late dy...

Detailed Description

In preparation for a randomised study in Denmark (DAHANCA 35) the feasibility of selecting newly diagnosed patients with squamous cell carcinoma of the pharynx or larynx for proton therapy at the loca...

Eligibility Criteria

Inclusion

  • Patients with histologically proven squamous cell carcinoma of the pharynx or larynx planned for primary radiotherapy with curative intent
  • A predicted clinical significant reduction in the risk of any of the two primary endpoints (\>= grade 2 observer-rated dysphagia or grade 2 patient-reported xerostomia) after proton therapy compared to photon therapy based on comparison of the individual patient dose plans
  • No current or earlier malignancies, which may influence treatment, evaluation or outcome of the head-neck cancer
  • Informed consent as required by law
  • Above 18 years of age

Exclusion

  • Patient with cancers of the glottic larynx (stage I/II), skull base, sino-nasal area, nasopharynx, unknown primary tumor and prior malignancies.
  • Patients with contraindications for proton therapy (as per 2019 pacemakers, implanted defibrillators and tracheostomy)
  • Inability to attend full course of radiotherapy or follow-up visits in the outpatient clinic
  • Distant metastasis
  • Previous radiotherapy of the head and neck
  • Previous surgery for the primary cancer with curative intent

Key Trial Info

Start Date :

May 20 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 14 2026

Estimated Enrollment :

63 Patients enrolled

Trial Details

Trial ID

NCT05423704

Start Date

May 20 2019

End Date

May 14 2026

Last Update

June 21 2022

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Aalborg University Hospital

Aalborg, Denmark

2

Aarhus University Hospital

Aarhus, Denmark

3

Danish Center for Particle Therapy

Aarhus, Denmark

4

Rigshospitalet

Copenhagen, Denmark